1. Home
  2. INDP vs EONR Comparison

INDP vs EONR Comparison

Compare INDP & EONR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INDP
  • EONR
  • Stock Information
  • Founded
  • INDP 2000
  • EONR 2020
  • Country
  • INDP United States
  • EONR United States
  • Employees
  • INDP N/A
  • EONR N/A
  • Industry
  • INDP Biotechnology: Pharmaceutical Preparations
  • EONR
  • Sector
  • INDP Health Care
  • EONR
  • Exchange
  • INDP Nasdaq
  • EONR NYSE
  • Market Cap
  • INDP 12.1M
  • EONR 10.7M
  • IPO Year
  • INDP N/A
  • EONR N/A
  • Fundamental
  • Price
  • INDP $1.13
  • EONR $1.00
  • Analyst Decision
  • INDP Strong Buy
  • EONR
  • Analyst Count
  • INDP 2
  • EONR 0
  • Target Price
  • INDP $8.50
  • EONR N/A
  • AVG Volume (30 Days)
  • INDP 305.3K
  • EONR 320.0K
  • Earning Date
  • INDP 11-12-2024
  • EONR 11-26-2024
  • Dividend Yield
  • INDP N/A
  • EONR N/A
  • EPS Growth
  • INDP N/A
  • EONR N/A
  • EPS
  • INDP N/A
  • EONR N/A
  • Revenue
  • INDP N/A
  • EONR $22,964,891.00
  • Revenue This Year
  • INDP N/A
  • EONR N/A
  • Revenue Next Year
  • INDP N/A
  • EONR N/A
  • P/E Ratio
  • INDP N/A
  • EONR N/A
  • Revenue Growth
  • INDP N/A
  • EONR N/A
  • 52 Week Low
  • INDP $1.03
  • EONR $0.81
  • 52 Week High
  • INDP $3.10
  • EONR $7.65
  • Technical
  • Relative Strength Index (RSI)
  • INDP 42.20
  • EONR N/A
  • Support Level
  • INDP $1.11
  • EONR N/A
  • Resistance Level
  • INDP $1.31
  • EONR N/A
  • Average True Range (ATR)
  • INDP 0.10
  • EONR 0.00
  • MACD
  • INDP -0.01
  • EONR 0.00
  • Stochastic Oscillator
  • INDP 14.34
  • EONR 0.00

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

About EONR EON RESOURCES INC

EON Resources Inc is an independent upstream energy company focused on maximizing total returns to its shareholders through the development of onshore oil and natural gas properties in the United States. Its current focus is as an upstream energy company producing oil and gas properties in the Permian Basin.

Share on Social Networks: